CARDIUM THERAPEUTICS INC NEW
CXM
CXM was delisted on the 23rd of January, 2014.
8 hedge funds and large institutions have $77K invested in CARDIUM THERAPEUTICS INC NEW in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
8% more capital invested
Capital invested by funds: $71K → $77K (+$6K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$28.4K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$8.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$19K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$37 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $29K | +$28.4K | +35,100 | New |
|
|
2
Creative Planning
Overland Park,
Kansas
| $21K | +$8.78K | +10,852 | +74% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $13K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $12K | – | – | – |
|
5
Canada Life
Winnipeg,
Manitoba, Canada
| $1K | – | – | – |
|
|
VIA
6
Vantage Investment Advisors
State College,
Pennsylvania
| $1K | +$1.09K | +1,350 | New |
|
|
7
Nomura Holdings
Tokyo,
Japan
| – | -$19K | -18,192 | Closed |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$2K | -2,262 | Closed |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | -$37 | -46 | -17% |
|
CXM Hedge Fund Activity: Q4 2013 in Review
8 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in CARDIUM THERAPEUTICS INC NEW (CXM) for Q4 2013, worth a combined $77K — up 8.5% from $71K a quarter earlier.
Fund positioning in CXM was balanced in Q4 2013: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $28.4K. The largest seller was Nomura Holdings, exiting entirely with an estimated $19K sold.
- 8 institutional investors held CARDIUM THERAPEUTICS INC NEW (CXM) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $77K of CARDIUM THERAPEUTICS INC NEW stock for Q4 2013, up 8.5% quarter-over-quarter.
- 2 funds opened new CARDIUM THERAPEUTICS INC NEW positions in Q4 2013 and 2 closed out, a net change of 0 holders.
- The largest CARDIUM THERAPEUTICS INC NEW buyer in Q4 2013 was Renaissance Technologies, an estimated $28.4K added.
- The largest CARDIUM THERAPEUTICS INC NEW seller in Q4 2013 was Nomura Holdings, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2013.